Laminin α-3, a key component of the laminin family of extracellular matrix (ECM) proteins, plays a crucial role in the structural integrity and function of various tissues, particularly in the basement membranes of epithelial tissues. As an essential constituent of the ECM, laminin α-3 contributes to cell adhesion, migration, differentiation, and tissue organization. It interacts with other laminin isoforms, integrins, and cell surface receptors to form stable adhesion complexes that anchor cells to the basement membrane and transmit signals bidirectionally between the ECM and the intracellular environment. In addition to its structural role, laminin α-3 also functions as a signaling molecule, modulating cellular processes such as proliferation, survival, and differentiation through interactions with its cell surface receptors.
The activation of laminin α-3 is primarily mediated by cell-matrix interactions and the engagement of its cell surface receptors, including integrins and non-integrin receptors such as dystroglycan and Lutheran blood group glycoprotein. Upon binding to these receptors, laminin α-3 initiates a series of intracellular signaling events that activate downstream signaling pathways, including the integrin-linked kinase (ILK) pathway, the phosphoinositide 3-kinase (PI3K)-Akt pathway, and the mitogen-activated protein kinase (MAPK) pathway. These pathways regulate various cellular processes, including cytoskeletal remodeling, gene expression, and cell survival, ultimately leading to the activation of cellular responses associated with tissue development, homeostasis, and repair. Furthermore, the proteolytic cleavage of laminin α-3 by specific enzymes can also generate bioactive fragments that exert regulatory effects on cell behavior and tissue function, contributing to the dynamic regulation of laminin α-3 activity in physiological and pathological conditions. Overall, the activation of laminin α-3 represents a fundamental mechanism for maintaining tissue integrity, function, and homeostasis in multicellular organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could potentially enhance L-Myc expression through its role in cell differentiation by binding to retinoic acid receptors that regulate gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone might activate L-Myc expression through glucocorticoid receptor-mediated effects on cellular transcription processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could elevate L-Myc levels by activating adenylate cyclase, thus increasing cAMP levels and influencing transcription factors. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium might indirectly activate L-Myc expression via its impact on glycogen synthase kinase-3 (GSK-3) signaling pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, may enhance L-Myc expression by causing chromatin remodeling, thus affecting gene accessibility. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline could potentially activate L-Myc expression indirectly through its influence on mitochondrial protein synthesis and cell metabolism. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone may activate L-Myc expression due to its role in stress response and interaction with specific corticosteroid receptors. | ||||||